297 filings
8-K/A
JNJ
Johnson & Johnson
16 Apr 24
Johnson & Johnson Reports Q1 2024 Results
12:16pm
8-K
JNJ
Johnson & Johnson
16 Apr 24
Johnson & Johnson Reports Q1 2024 Results
7:06am
8-K
JNJ
Johnson & Johnson
23 Jan 24
Johnson & Johnson Reports Q4 and Full-Year 2023 Results
7:45am
8-K
JNJ
Johnson & Johnson
5 Dec 23
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
4:42pm
8-K
JNJ
Johnson & Johnson
5 Dec 23
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review
7:52am
8-K
yoz t1e3i1744
30 Nov 23
Strengthens position in high-growth MedTech segments
4:30pm
8-K
a97jk1 pabr
27 Nov 23
Departure of Directors or Certain Officers
4:56pm
8-K
rqeft se0yz6c0j
23 Oct 23
Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech
4:48pm
8-K
ug19sr e9asu
17 Oct 23
Results of Operations and Financial Condition
7:33am
8-K
h8sz njnu
30 Aug 23
Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation
7:46am
8-K
aso9zlb47
25 Aug 23
Completion of Acquisition or Disposition of Assets
5:02pm
8-K
z00c7j5fuq4dm
28 Jul 23
Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
4:08pm
8-K
eefradw6tc 3mrfkgqr
24 Jul 23
Other Events
6:20am
8-K
639f3 z5l6lb8ll8rc
20 Jul 23
Results of Operations and Financial Condition
7:15am
8-K
0iz0xfk
8 May 23
Entry into a Material Definitive Agreement
4:23pm
8-K
sd9pj6z
28 Apr 23
Departure of Directors or Certain Officers
6:14pm
8-K
nk0c3js1aflbe
18 Apr 23
Results of Operations and Financial Condition
7:29am
8-K
2f0m jqy9ob
4 Apr 23
Regulation FD Disclosure
4:12pm
8-K
x3mlx6l 7pqu
31 Mar 23
Departure of Directors or Certain Officers
7:29pm
8-K/A
sgfzwpcv6h
14 Feb 23
Departure of Directors or Certain Officers
5:55pm